Additionally, the adiponectin level and ADIPOR1/ADIPOR2 expression are reduced in obesity and obesity-related diseases and likely contribute to the characteristic low-grade inflammation because of the absence of the anti-inflammatory effects of adiponectin [39]. Here, ADIPOQ is linked to obesity disorder.